Filtros : "HIV" "IAVI" Removidos: "FÁRMACOS" "FMRP-RBP" Limpar

Filtros



Refine with date range


  • Source: PLOS ONE. Unidade: FM

    Subjects: INCIDÊNCIA, ANTÍGENOS DE VÍRUS, HIV, SURTOS DE DOENÇAS, VIGILÂNCIA DA POPULAÇÃO, CARGA VIRAL, INFECÇÕES POR HIV, QUÊNIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SEMPA, Joseph B et al. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance. PLOS ONE, v. 14, n. 7, 2019Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0220345. Acesso em: 10 nov. 2024.
    • APA

      Sempa, J. B., Welte, A., Busch, M. P., Hall, J., Hampton, D., Facente, S. N., et al. (2019). Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance. PLOS ONE, 14( 7). doi:10.1371/journal.pone.0220345
    • NLM

      Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Kallas EG. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance [Internet]. PLOS ONE. 2019 ; 14( 7):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0220345
    • Vancouver

      Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Kallas EG. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance [Internet]. PLOS ONE. 2019 ; 14( 7):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0220345
  • Source: Jaids-journal of acquired immune deficiency syndromes. Unidade: FM

    Subjects: BIOMARCADORES, IMUNOENSAIO, WESTERN BLOTTING, HIV

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GREBE, Eduard e KALLAS, Esper G. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms. Jaids-journal of acquired immune deficiency syndromes, v. 76, n. 5, p. 547-555, 2017Tradução . . Disponível em: https://doi.org/10.1097/QAI.0000000000001537. Acesso em: 10 nov. 2024.
    • APA

      Grebe, E., & Kallas, E. G. (2017). Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms. Jaids-journal of acquired immune deficiency syndromes, 76( 5), 547-555. doi:10.1097/QAI.0000000000001537
    • NLM

      Grebe E, Kallas EG. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms [Internet]. Jaids-journal of acquired immune deficiency syndromes. 2017 ; 76( 5): 547-555.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/QAI.0000000000001537
    • Vancouver

      Grebe E, Kallas EG. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms [Internet]. Jaids-journal of acquired immune deficiency syndromes. 2017 ; 76( 5): 547-555.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/QAI.0000000000001537

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024